Minka Therapeutics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Minka Therapeutics SA(Minka Therapeutics) formerly known as InnaVirVax SA, is a biopharmaceutical company which discovers and develops products for the treatment of HIV/AIDS infection pathologically and novel cancer therapies. The companys pipeline product portfolio comprise DIAG-3S, an AIDS prognostic test; VAC-3S, an HIV AIDs therapeutic vaccine protecting the cd4+ t lymphocytes from depletion; VAC02, a vaccine project for the prophylactic vaccination against HIV injection, and others. Minka Therapeutics works in collaboration with pharmaceutical companies, biotechnology companies and research institutes for the further development and commercialization of its vaccine candidates. The company develops a potent vaccine technology platform which can generate high levels of antibodies targeted against the used peptide antigens. Minka Therapeutics is headquartered in Evry, France.

Minka Therapeutics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Minka Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Minka Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 9
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
InnaVirVax Raises USD4 Million in Venture Financing 11
InnaVirVax Raises US$4.9 Million In Series B Financing 12
Partnerships 13
FIT Biotech Enters into Agreement with InnaVirVax 13
Minka Therapeutics SA - Key Competitors 14
Minka Therapeutics SA - Key Employees 15
Minka Therapeutics SA - Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables


Minka Therapeutics SA, Pharmaceuticals & Healthcare, Key Facts 2
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Minka Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Minka Therapeutics SA, Deals By Therapy Area, 2012 to YTD 2018 8
Minka Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 9
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InnaVirVax Raises USD4 Million in Venture Financing 11
InnaVirVax Raises US$4.9 Million In Series B Financing 12
FIT Biotech Enters into Agreement with InnaVirVax 13
Minka Therapeutics SA, Key Competitors 14
Minka Therapeutics SA, Key Employees 15

List Of Figures


Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Minka Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Minka Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 9

Minka Therapeutics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Minka Therapeutics SA(Minka Therapeutics) formerly known as InnaVirVax SA, is a biopharmaceutical company which discovers and develops products for the treatment of HIV/AIDS infection pathologically and novel cancer therapies. The

USD 250 View Report

ADC Therapeutics SA - Pharmaceuticals and Healthcare - Deals and Alliances Profile

ADC Therapeutics SA (ADCT) is a pharmaceutical company that develops a pipeline of proprietary antibody drug conjugates for the treatment of both solid and hematological cancers. The company offers combining

USD 250 View Report

Bone Therapeutics SA (BOTHE) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available